Related Experiment Videos
Screening test of anticancer drugs on human osteosarcoma heterotransplanted in nude mice
Abstract:
Following amputation of a limb for osteosarcoma, the tumour was serially transferred to nude mice. The rate of growth was determined and the inhibitory effect of Cyclophosphamide, Adriamycin and 5-Fluorouracil was assessed in three separate experimental animal groups. In the tumour studied. Cyclophosphamide produced the greatest inhibition of tumour growth, mitotic index and cytokinetic studies. The technique may be helpful in screening the sensitivity of other types of human malignant tumour.
Insights
Cyclophosphamide effectively inhibited osteosarcoma tumor growth in mice. This study demonstrates a method for screening chemotherapy drug sensitivity in human malignant tumors.
Area of Science:
- Oncology
- Pharmacology
- Animal Models
Background:
- Osteosarcoma is a primary malignant bone tumor often requiring amputation.
- Evaluating chemotherapy drug efficacy is crucial for treatment planning.
- Nude mice xenografts provide a model for studying human tumor growth.
Purpose of the Study:
- To assess the inhibitory effects of Cyclophosphamide, Adriamycin, and 5-Fluorouracil on osteosarcoma xenografts.
- To evaluate a serial tumor transfer technique in nude mice for drug sensitivity screening.
Main Methods:
- Osteosarcoma tumor tissue was serially transferred to nude mice.
- Tumor growth rates were monitored.
- Inhibitory effects of Cyclophosphamide, Adriamycin, and 5-Fluorouracil were assessed in separate experimental groups.
Main Results:
- Cyclophosphamide demonstrated the most significant inhibition of osteosarcoma tumor growth.
- Cytokinetic and mitotic index studies corroborated the inhibitory effects of Cyclophosphamide.
- Tumor growth rates varied among the different drug treatment groups.
Conclusions:
- Cyclophosphamide is a highly effective agent against the studied osteosarcoma xenograft.
- Serial tumor transfer in nude mice is a viable technique for screening chemotherapy sensitivity.
- This model holds potential for evaluating drug responses in various human malignant tumors.